Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News United Therapeutics Corporation UTHR

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin... see more

Current News (NDAQ:UTHR)

United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference

Business Wire 3 days ago

United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026

Business Wire 4 days ago

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

GlobeNewswire 9 days ago

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

Business Wire 9 days ago

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors

Business Wire April 29, 2026

United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026

Business Wire April 22, 2026

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

Business Wire April 20, 2026

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

Business Wire April 8, 2026

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2

Business Wire March 30, 2026

Opinion & Analysis (NDAQ:UTHR)

Capitalizing on the "V-Bottom" with UTHR

Benzinga.com  October 21, 2014

Bullboard Posts (NDAQ:UTHR)

slow down

do you think we are headed for a great depression
Bullhunk - April 1, 2026

United Therapeutics Corp (NASDAQ:UTHR): A Specialized Biotec

http://beyondspx.com/2024/08/01/united-therapeutics-corp-nasdaquthr-a-specialized-biotech-powerhouse-delivering-consistent-growth/
MikeTester - August 2, 2024

BUY BUY BUY BUY BUY

With MIRO AQUISITION THIS THING SET TO FLY
Nibinator - October 30, 2023

Real stock price share value

148$
Nibinator - October 30, 2023

Insider Buying

http://www.gurufocus.com/news.php?id=58696
videomart - June 21, 2009

I agree

good poste I'm also interested in what united theroputics thoughts are on this deal with alterex and twinn butt
peechd - March 26, 2004

Podcasts